суббота, 18 февраля 2017 г.

Momenta Pharma shares halted as drug application hits speed bump

Momenta Pharma shares halted as drug application hits speed bump


Momenta shares were halted at $19 after hours. The company said a key supplier of its Glatopa multiple sclerosis drug, Pfizer Inc. was served with a Food and Drug Administration Warning Letter, meaning something at the Pfizer facility was not in compliance with FDA code.



from Biotech News